TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

Tulio E Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.